Competing biomedical HIV prevention strategies: potential cost-effectiveness of HIV vaccines and PrEP in Seattle, WA.

Blythe J S AdamsonLouis GarrisonRuanne V BarnabasJosh J CarlsonJames KublinDobromir Dimitrov

Published in: Journal of the International AIDS Society (2020)

Access to an HIV vaccine is desirable as it could increase the overall effectiveness of combination HIV prevention efforts and improve population health. Planning for the rollout and scale-up of HIV vaccines should carefully consider the design of policies that guide interactions between vaccine and PrEP utilization and potential competition.

Keyphrases

men who have sex with men
hiv testing
hiv positive
antiretroviral therapy
hiv infected
human immunodeficiency virus
hepatitis c virus
hiv aids
randomized controlled trial
systematic review
south africa
public health
risk assessment